Molibresib besylate
≥98%
- Product Code: 101530
CAS:
1895049-20-3
| Molecular Weight: | 582.0700000000001 g./mol | Molecular Formula: | C₂₈H₂₈ClN₅O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Molibresib besylate is primarily used in the field of oncology as a targeted therapy for certain types of cancers. It functions as a bromodomain and extraterminal (BET) inhibitor, which means it interferes with the proteins that play a crucial role in the regulation of gene expression, particularly those involved in cancer cell growth and survival. This makes it a potential treatment option for hematologic malignancies such as acute myeloid leukemia (AML) and myelofibrosis. Additionally, it is being investigated for its efficacy in solid tumors, where it may help in reducing tumor growth and improving patient outcomes. The compound is often utilized in clinical trials to assess its safety, tolerability, and effectiveness in various cancer types, offering hope for more personalized and effective cancer treatments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | $302.61 |
+
-
|
| 0.005 | 10-20 days | $443.83 |
+
-
|
Molibresib besylate
Molibresib besylate is primarily used in the field of oncology as a targeted therapy for certain types of cancers. It functions as a bromodomain and extraterminal (BET) inhibitor, which means it interferes with the proteins that play a crucial role in the regulation of gene expression, particularly those involved in cancer cell growth and survival. This makes it a potential treatment option for hematologic malignancies such as acute myeloid leukemia (AML) and myelofibrosis. Additionally, it is being investigated for its efficacy in solid tumors, where it may help in reducing tumor growth and improving patient outcomes. The compound is often utilized in clinical trials to assess its safety, tolerability, and effectiveness in various cancer types, offering hope for more personalized and effective cancer treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :